Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT

Lancet

Volumn 349, Issue 9053, 1997, Pages 675-682

  Cairns, John A ^a,b   Connolly, Stuart J ^a   Roberts, Robin ^a   Gent, Michael ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SLEEP DISORDER; THYROID DISEASE; TREATMENT OUTCOME; VISUAL DISORDER;

EID: 0031029373     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08171-8     Document Type: Article

References (17)

1. LeFeuvre CA, Connolly SJ, Cairns JA, Gent M, Roberts RS. Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically-defined stable population. Am J Cardiol (in press).
2. Davis HT, de Camilla J, Bayer LW, Moss AJ. Survivorship patterns in posthospital phase of myocardial infarction. Circulation 1979; 60: 998-1003.
3. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J M ed 1983; 309: 331-36.
4. Villella A, Maggioni AP, Giordano A, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Lancet 1995; 346: 523-29.
5. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993; 87: 512-22.
6. Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 1983; 52 (suppl): 32C-36C.
7. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J M ed 1989; 321: 406-12.
8. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J M ed 1992; 327: 227-33.
9. Teo KK, Yusuf S, Furburg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled clinical trials. JAMA 1993; 270: 1589-95.
10. Podrid PJ. Amiodarone: re-evaluation of an old drug. Ann Intern M ed 1995; 122: 689-700.
11. Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality of survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990; 16: 1711-18.
12. Ceremuzynski L, Leczar E, Krzeminska-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardol 1992; 20: 1056-62.
13. Cairns JA, Connolly SC, Gent M, Roberts RS. Post myocardial infarction mortality in patients with ventricular premature depolarizations: Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study. Circulation 1991; 84: 550-57.
14. Cairns JA, Connolly SJ, Roberts RS, Gent M. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. Am J Cardiol 1993; 72: 87F-94F.
15. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7-12.
16. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J M ed 1993; 329: 673-82.
17. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-28.